UNSPSC 85283004: Diagnosis of progressive relapsing multiple sclerosis

This classification denotes the group of activities that yields a Progressive Relapsing Multiple Sclerosis

UNSPSC 85283004 Diagnosis of progressive relapsing multiple sclerosis is a Commodity code whose recent state and local solicitations show little alignment with the code's nominal scope. The three most recent opportunities posted under this code span diagnostic imaging system implementation (San Mateo Medical Center's PACS solicitation), ultrasound equipment procurement (Collier County's single-source notice for EchoNous equipment), and phlebotomy services (Albuquerque Police Department's blood draw service RFB) — none of which target diagnosis of progressive relapsing multiple sclerosis specifically. State and local buyers tagging opportunities under this code appear to be using it as a catch-all for diagnostic and clinical services rather than as a disease-specific procurement category. The issuing bodies include a county health system (San Mateo County Medical Center), a county procurement office (Collier County), and a city police department (Albuquerque), suggesting the code captures a broad range of government health and safety service procurement with no clear concentration in any single jurisdiction type.

Geographic activity appears scattered across California, Florida, and New Mexico with no evident regional concentration. The most substantive recent opportunity is San Mateo Medical Center's RFP for enterprise-grade PACS implementation (due August 7, 2026) supporting radiology, cardiology, and dental imaging with EPIC integration, requiring vendors to demonstrate prior public-sector PACS implementations and offering local preference under San Mateo County Ordinance; Collier County issued a single-source notice of intent for specialized ultrasound equipment (deadline March 26, 2026, now closed); and Albuquerque's RFB for on-call phlebotomy services across Bernalillo County (due February 25, 2026, now closed) projected approximately 300 annual service calls with a potential three-year initial term. The code shows minimal relevant recent procurement activity aligned with its stated diagnostic focus, suggesting it warrants monitoring only if your firm pursues general clinical services or diagnostic equipment work without disease-specific requirements.